Veristat Continues Decade Long Preferred Partnership with EndoCeutics
Veristat Assists EndoCeutics with NDA Submission for Intravaginal Prasterone
Veristat Recognized as One of America’s Fast-Growing Companies on the 2015 Inc. 5000 List
Veristat announced that it has been recognized by Inc. Magazine as one of the Countries’...
Veristat Completes Move into New Corporate Headquarters
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO),...
Veristat Expands Its San Francisco Bay Area Operations: Opens New Office to Support Life Sciences Firms
HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO),...